| Literature DB >> 23853769 |
Maryam Zahin1, Farrukh Aqil, Fohad Mabood Husain, Iqbal Ahmad.
Abstract
It is well known that the intake of antioxidants with increased consumption of fruits and vegetables and medicinal herbs contributes towards reduced risk of certain diseases including cancers. This study aims to evaluate the broad-spectrum antioxidant and antimutagenic activities as well as to elucidate phytochemical profile of an Indian medicinal plant Murraya koenigii (curry) leaves. Leaves of the plant were successively fractionated in various organic solvents. Benzene fraction demonstrated the highest phenolic content followed by petroleum ether. The benzene fraction showed maximum antioxidant activity in all tested assays, namely, phosphomolybdenum, 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical, ferric reducing antioxidant power (FRAP) and cupric reducing antioxidant capacity (CUPRAC) assays. Based on the promising broad-spectrum antioxidant activity, benzene fraction was further evaluated for antimutagenic activity and showed a dose-dependent antimutagenic response in Ames Salmonella mutagenicity assay. It inhibited 72-86% mutagenicity induced by sodium azide, methyl methanesulfonate, benzo(a)pyrene, and 2-aminoflourene at the maximum tested concentration (100 μg/mL) in Salmonella typhimurium tester strains. At least 21 compounds were detected by GC/MS. The findings clearly demonstrated that phenolic-rich benzene fraction has promising broad-spectrum antioxidant and antimutagenic property and needs further evaluation to exploit its therapeutic potential.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23853769 PMCID: PMC3703397 DOI: 10.1155/2013/263509
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Antioxidant capacity of Murraya koenigii leaf fractions expressed as ascorbic acid equivalents (µmol/g of extract) by phosphomolybdenum method.
| Concentration ( | Antioxidant capacity ( | |||||
|---|---|---|---|---|---|---|
| Petrol ether | Benzene | Ethyl acetate | Acetone | Methanol | Ethanol | |
| 12.5 | 980.0d ± 18.3 | 1669.8d ± 21.1 | 939.4d ± 43.4 | 702.4d ± 26.2 | 261.0d ± 15.8 | 303.7d ± 13.4 |
| 25 | 1531.6c ± 50.7 | 2459.5c ± 75.4 | 1399.2c ± 19.5 | 1233.8c ± 47.1 | 398.5c ± 21.2 | 419.3c ± 10.1 |
| 50 | 1663.0b ± 56.9 | 3132.3b ± 97.2 | 1589.2b ± 66.9 | 1438.5b ± 39.4 | 522.5b ± 12.6 | 542.3b ± 16.6 |
| 100 | 1967.2a ± 67.4 | 3510.4a ± 95.8 | 1982.3a ± 84.3 | 1783.0a ± 86.4 | 638.7a ± 25.1 | 668.8a ± 15.3 |
|
| ||||||
| LSD at 5% | 109.01 | 116.04 | 102.06 | 81.02 | 43.89 | 7.93 |
The above data are the mean of three experiments ± SD; different letters in columns show significant difference in means. LSD: least significance difference.
Figure 1DPPH free radical scavenging activity of Murraya koenigii leaf fractions (petroleum ether, benzene, ethyl acetate, acetone, methanol, and ethanol) at different concentrations (12.5–100 μg/mL). The activity is compared with commercial antioxidants, ascorbic acid and BHT. Each data point represents the mean of three experiments. Standard deviation (≤4%) is not shown for clarity of the data.
Figure 2Reducing power of Murraya koenigii leaf fractions (petroleum ether, benzene, ethyl acetate, acetone, methanol, and ethanol). The extracts were tested in the range of 10–100 μg/mL concentrations in FRAP (a) and CUPRAC (b) assays and compared with ascorbic acid and BHT. Each data point represents the mean of three experiments. Standard deviation (≤4%) is not shown for clarity of the data.
Effect of benzene fraction of Murraya koenigii on the mutagenicity induced by sodium azide (NaN3) using Salmonella typhimurium strains.
| Treatment | Dose ( | Number of His+ revertants colonies/plate | |||
|---|---|---|---|---|---|
| TA97a | TA98 | TA100 | TA102 | ||
| Spontaneous | 140.0 ± 4.0 | 31.0 ± 3.6 | 128.7 ± 9.8 | 245.7 ± 23.3 | |
| Positive control (NaN3) | 1.5 | 246.3 ± 16.0 | 52.7 ± 2.1 | 352.0 ± 33.0 | 343.3 ± 33.3 |
|
a
| 12.5 | 164.3 ± 12.3 | 46.0 ± 4.0 | 191.7 ± 13.3 | 286.7 ± 26.3 |
| 25 | 145.0 ± 15.5 | 37.3 ± 7.0 | 172.3 ± 18.9 | 260.0 ± 24.1 | |
| 50 | 124.7 ± 9.1 | 30.7 ± 8.5 | 153.0 ± 19.7 | 245.3 ± 24.4 | |
| 100 | 118.0 ± 10.5 | 24.0 ± 4.6 | 127.0 ± 15.5 | 228.3 ± 19.6 | |
|
b
| 12.5 | 225.3 ± 33.6 (25.6) | 51.3 ± 6.0 (20.0) | 316.3 ± 32.0 (22.3) | 332.3 ± 34.9 (19.4) |
| 25 | 200.7 ± 22.7* (45.1) | 45.3 ± 4.2 (47.8) | 258.0 ± 29.6* (52.3) | 313.0 ± 32.1 (36.4) | |
| 50 | 168.0 ± 22.3** (64.4) | 39.0 ± 8.2* (62.1) | 212.7 ± 26.6** (70.0) | 292.7 ± 18.6 (51.7) | |
| 100 | 137.3 ± 12.7*** (84.9) | 31.7 ± 6.5** (73.2) | 162.0 ± 21.0** (84.4) | 260.3 ± 14.0* (72.2) | |
|
| |||||
|
| 18.069 | 8.288 | 33.690 | 6.917 | |
|
| |||||
|
| 0.999 | 0.953 | 0.969 | 0.996 | |
The data represented in the table is the mean ± SD values of three replicates. Mean values followed by asterisk are significantly different when compared to positive control at *P < 0.05, **P < 0.005, and ***P < 0.001. The values in parentheses are the inhibition rates of mutagenicity (%). Positive control: NaN3, sodium azide. aNegative control; bpreincubation test; R 2: linear regression analysis.
Effect of benzene fraction of Murraya koenigii on the mutagenicity induced by 2-aminofluorene (2-AF) with metabolic activation using Salmonella typhimurium strains.
| Treatment | Dose ( | Number of His+ revertants colonies/plate | |||
|---|---|---|---|---|---|
| TA97a | TA98 | TA100 | TA102 | ||
| Spontaneous | 143.7 ± 13.2 | 37.0 ± 3.0 | 135.3 ± 9.5 | 316.0 ± 14.5 | |
| Positive control (2AF) | 5 | 328.0 ± 12.0 | 262.3 ± 17.2 | 502.0 ± 19.1 | 1430.3 ± 32.5 |
|
a
| 12.5 | 142.0 ± 18.3 | 50.3 ± 2.5 | 132.7 ± 16.0 | 265.0 ± 28.2 |
| 25 | 156.0 ± 14.4 | 42.7 ± 3.5 | 155.3 ± 17.2 | 296.3 ± 17.6 | |
| 50 | 168.7 ± 21.7 | 35.0 ± 3.6 | 168.0 ± 18.0 | 322.7 ± 31.1 | |
| 100 | 181.3 ± 27.1 | 28.0 ± 3.6 | 175.3 ± 20.6 | 340.3 ± 31.3 | |
|
b
| 12.5 | 276.3 ± 31.1 (27.8) | 200.7 ± 17.0* (29.1) | 422.3 ± 32.7* (21.6) | 1185.3 ± 77.0** (21.0) |
| 25 | 248.7 ± 28.0* (46.1) | 161.0 ± 12.5** (46.1) | 346.3 ± 21.6*** (44.9) | 960.7 ± 70.8*** (41.4) | |
| 50 | 220.0 ± 25.0** (67.8) | 114.7 ± 13.1*** (65.0) | 280.7 ± 27.0*** (66.3) | 655.0 ± 55.3*** (70.0) | |
| 100 | 202.3 ± 14.2*** (85.7) | 70.0 ± 7.6*** (82.1) | 205.0 ± 18.0*** (90.9) | 462.0 ± 32.9*** (88.8) | |
|
| |||||
|
| 24.643 | 197.239 | 37.820 | 276.179 | |
|
| |||||
|
| 0.987 | 0.999 | 0.999 | 0.994 | |
The data represented in the table is the mean ± SD values of three replicates. Mean values followed by asterisk are significantly different when compared to positive control at *P < 0.05; **P < 0.005 and ***P < 0.001. The values in parentheses are the inhibition rates of mutagenicity (%). Positive control: 2-AF, 2-aminoflourene.aNegative control; bPre-incubation test; R 2: Linear regression analysis.
Effect of benzene fraction of Murraya koenigii on the mutagenicity induced by methyl methanesulfonate (MMS) using Salmonella typhimurium strains.
| Treatment | Dose ( | Number of His+ revertants colonies/plate | |||
|---|---|---|---|---|---|
| TA97a | TA98 | TA100 | TA102 | ||
| Spontaneous | 140.0 ± 4.0 | 31.0 ± 3.6 | 128.7 ± 9.8 | 245.7 ± 23.3 | |
| Positive control (MMS) | 1 | 443.7 ± 19.9 | 51.0 ± 2.7 | 952.7 ± 46.0 | 1195.3 ± 79.0 |
|
a
| 12.5 | 164.3 ± 12.3 | 46.0 ± 4.0 | 191.7 ± 13.3 | 286.7 ± 26.3 |
| 25 | 145.0 ± 15.5 | 37.3 ± 7.0 | 172.3 ± 18.9 | 260.0 ± 24.1 | |
| 50 | 124.7 ± 9.1 | 30.7 ± 8.5 | 153.0 ± 19.7 | 245.3 ± 24.4 | |
| 100 | 118.0 ± 10.5 | 24.0 ± 4.6 | 127.0 ± 15.5 | 228.3 ± 19.6 | |
|
b
| 12.5 | 388.3 ± 31.2 (19.8) | 50.3 ± 4.0 (13.4) | 802.3 ± 57.1* (19.8) | 862.3 ± 58.8** (36.6) |
| 25 | 309.0 ± 30.8* (45.1) | 45.0 ± 4.6 (43.9) | 565.0 ± 45.1*** (49.7) | 675.3 ± 56.9*** (55.6) | |
| 50 | 239.7 ± 20.2** (63.9) | 38.3 ± 4.0* (62.3) | 440.7 ± 48.6*** (64.0) | 518.0 ± 32.1*** (71.3) | |
| 100 | 183.0 ± 17.5*** (80.0) | 31.0 ± 5.6** (74.1) | 262.3 ± 31.7*** (83.6) | 363.7 ± 37.1*** (86.0) | |
|
| |||||
|
| 81.635 | 9.877 | 225.881 | 178.255 | |
|
| |||||
|
| 0.989 | 0.958 | 0.978 | 0.996 | |
The data represented in the table is the mean ± SD values of three replicates. Mean values followed by asterisk are significantly different when compared to positive control at *P < 0.05; **P < 0.005 and ***P < 0.001. The values in parentheses are the inhibition rates of mutagenicity (%). Positive control: MMS: methyl methanesulfonate. aNegative control; bPre-incubation; R 2: Linear regression analysis.
Effect of benzene fraction of Murraya koenigii on the mutagenicity induced by benzo(a)pyrene with metabolic activation using Salmonella typhimurium strains.
| Treatment | Dose ( | Number of His+ revertants colonies/plate | |||
|---|---|---|---|---|---|
| TA97a | TA98 | TA100 | TA102 | ||
| Spontaneous | 143.7 ± 13.2 | 37.0 ± 3.0 | 135.3 ± 9.5 | 316.0 ± 14.5 | |
| Positive control (BP) | 1 | 720.3 ± 28.5 | 155.0 ± 7.6 | 695.7 ± 17.0 | 648.0 ± 17.1 |
|
a
| 12.5 | 142.0 ± 18.3 | 50.3 ± 2.5 | 132.7 ± 16.0 | 265.0 ± 28.2 |
| 25 | 156.0 ± 14.4 | 42.7 ± 3.5 | 155.3 ± 17.2 | 296.3 ± 17.6 | |
| 50 | 168.7 ± 21.7 | 35.0 ± 3.6 | 168.0 ± 18.0 | 322.7 ± 31.1 | |
| 100 | 181.3 ± 27.1 | 28.0 ± 3.6 | 175.3 ± 20.6 | 340.3 ± 31.3 | |
|
b
| 12.5 | 592.3 ± 44.5* (22.1) | 132.7 ± 19.2 (21.3) | 540.0 ± 50.1** (27.7) | 560.3 ± 31.2* (22.9) |
| 25 | 501.7 ± 36.6** (38.7) | 101.0 ± 19.3* (48.1) | 435.3 ± 46.1*** (48.2) | 501.7 ± 16.9*** (41.9) | |
| 50 | 382.7 ± 35.6*** (61.2) | 80.7 ± 12.7*** (61.9) | 352.3 ± 30.7*** (65.1) | 436.0 ± 38.2*** (65.2) | |
| 100 | 276.0 ± 26.5*** (82.4) | 53.3 ± 13.9*** (80.1) | 253.7 ± 21.4*** (84.9) | 382.0 ± 29.2*** (86.0) | |
|
| |||||
|
| 168.149 | 49.036 | 149.651 | 67.488 | |
|
| |||||
|
| 0.996 | 0.982 | 0.999 | 0.999 | |
The data represented in the table is the mean ± SD values of three replicates. Mean values followed by asterisk are significantly different when compared to positive control at *P < 0.05; **P < 0.005 and ***P < 0.001. The values in parentheses are the inhibition rates of mutagenicity (%). Positive control: BP: benzo(a)pyrene.aNegative control; bPre-incubation test; R 2: Linear regression analysis.
Components of Murraya koenigii benzene fraction as identified by GC-MS analysis.
| Peak no. | Components | Retention time | Area (%) |
|---|---|---|---|
| (1) | Caryophyllene | 11.19 | 14.8 |
| (2) |
| 11.77 | 2.79 |
| (3) | 1H-Cyclopropa[a] naphthalene, 1a,2, | 12.37 | 2.93 |
| (4) | Caryophyllene oxide | 13.24 | 6.61 |
| (5) | Spiro[4.4]nonan-2-one | 13.60 | 2.49 |
| (6) | 10,10-Dimethyl-2,6-dimethylenebicy | 13.93 | 3.32 |
| (7) | D-Limonene | 14.10 | 6.01 |
| (8) | Propylparaben | 15.80 | 6.11 |
| (9) | Salicylamide | 16.00 | 1.42 |
| (10) | 9-Borabicyclo[3.3.1]nonane, 9-hydr | 18.55 | 5.72 |
| (11) | 1,2-Diphenylethanethione | 18.69 | 0.54 |
| (12) | Phytol | 18.91 | 9.17 |
| (13) | 11,14-Eicosadienoic acid, methyl e | 19.44 | 2.59 |
| (14) | 3-Undecen-5-yne, (Z)- | 19.58 | 9.52 |
| (15) | Phenol, 2-methoxy-4-[2-(4-hydroxyphenyl)] | 20.71 | 1.94 |
| (16) | 2,6-Octadien-1-ol, 3,7-dimethyl-, | 22.41 | 1.06 |
| (17) | Docosane, 11-butyl- | 23.95 | 5.30 |
| (18) | 2-Methyl-3H-phenanthro[3,4-D] imida | 24.02 | 8.90 |
| (19) | Propanenitrile | 24.52 | 2.21 |
| (20) | Pentatriacontane | 25.82 | 4.22 |
| (21) | Vitamin A aldehyde | 26.57 | 2.33 |